GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B Turnover 46.55%
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
-6.87%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$3.98B
AUM Growth
-$931M
Cap. Flow
-$684M
Cap. Flow %
-17.16%
Top 10 Hldgs %
60.92%
Holding
66
New
9
Increased
17
Reduced
15
Closed
22
Avg Time Held Equity + Options
2.1 years
Top 10 Avg Time Held Equity + Options
1.6 years
Top 20 Avg Time Held Equity + Options
1.6 years
Avg Time Held Equity only
2.3 years
Top 10 Avg Time Held Equity only
2.4 years
Top 20 Avg Time Held Equity only
1.6 years

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$71.2M
2
HUM icon
Humana
HUM
+$68.6M
3
CI icon
Cigna
CI
+$60.7M
4
UBER icon
Uber
UBER
+$57.6M
5
CNC icon
Centene
CNC
+$55.7M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$324M
2
DOCN icon
DigitalOcean
DOCN
+$111M
3
THC icon
Tenet Healthcare
THC
+$96.7M
4
EXPE icon
Expedia Group
EXPE
+$91.1M
5
KNX icon
Knight Transportation
KNX
+$76.3M

Sector Composition

Rank Sector Weight
1 Healthcare 45.27%
2 Technology 18.54%
3 Industrials 11.89%
4 Consumer Discretionary 9.84%
5 Miscellaneous 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CVS icon
1
CVS Health
CVS
$115B
$589M 14.78%
8,196,799
– –
2023 Q4
9 quarters
GPN icon
2
Global Payments
GPN
$21.1B
$428M 10.75%
6,360,392
+439,273
+7% +$32.4M
2020 Q4
21 quarters
THC icon
3
Tenet Healthcare
THC
$22B
$288M 7.22%
1,524,854
-458,899
-23% -$96.7M
2013 Q2
51 quarters
AMZN icon
4
Amazon
AMZN
$2.74T
$221M 5.54%
1,059,270
+150,000
+16% +$33M
2023 Q1
12 quarters
TEVA icon
5
Teva Pharmaceutical Industries Limited
TEVA
$48.7B
$201M 5.04%
6,660,220
-10,059,989
-60% -$324M
2023 Q4
9 quarters
QQQ icon
6
CALL
Invesco QQQ Trust
QQQ
$488B
$189M 4.76%
+328,200
New +$199M
2026 Q1
0 quarters
CI icon
7
Cigna
CI
$76.2B
$133M 3.34%
498,841
+219,474
+79% +$60.7M
2013 Q2
51 quarters
AMD icon
8
Advanced Micro Devices
AMD
$932B
$132M 3.32%
650,792
+256,604
+65% +$54.8M
2025 Q4
1 quarter
TMO icon
9
Thermo Fisher Scientific
TMO
$249B
$123M 3.09%
250,525
+26,578
+12% +$14.4M
2025 Q2
3 quarters
VTRS icon
10
Viatris
VTRS
$20.4B
$123M 3.08%
9,087,244
-2,000,000
-18% -$28M
2023 Q4
9 quarters
DXC icon
11
DXC Technology
DXC
$2.01B
$112M 2.81%
8,895,875
+579,528
+7% +$7.78M
2017 Q2
35 quarters
CNC icon
12
Centene
CNC
$34.2B
$105M 2.64%
3,213,646
+1,357,752
+73% +$55.7M
2025 Q3
2 quarters
UBER icon
13
Uber
UBER
$141B
$105M 2.63%
1,455,872
+748,171
+106% +$57.6M
2021 Q2
19 quarters
GTM icon
14
ZoomInfo Technologies
GTM
$1.13B
$95.1M 2.39%
15,905,242
-4,100,000
-20% -$30.2M
2024 Q2
7 quarters
IWM icon
15
PUT
iShares Russell 2000 ETF
IWM
$76.4B
$93M 2.33%
+375,000
New +$96.7M
2026 Q1
0 quarters
XYZ icon
16
Block Inc
XYZ
$45.2B
$82.1M 2.06%
1,364,471
+512,978
+60% +$31.2M
2025 Q3
2 quarters
META icon
17
Meta Platforms (Facebook)
META
$1.87T
$70.2M 1.76%
122,662
+111,090
+960% +$71.2M
2025 Q1
4 quarters
AMAT icon
18
Applied Materials
AMAT
$355B
$67.4M 1.69%
197,209
+67,553
+52% +$22.7M
2025 Q4
1 quarter
ONTO icon
19
Onto Innovation
ONTO
$11.9B
$61.5M 1.54%
299,721
-115,091
-28% -$23.6M
2025 Q3
2 quarters
DKS icon
20
Dick's Sporting Goods
DKS
$13.4B
$59.3M 1.49%
298,911
+15,000
+5% +$3.04M
2025 Q2
3 quarters
HUM icon
21
Humana
HUM
$51.4B
$58.1M 1.46%
+334,892
New +$68.6M
2026 Q1
0 quarters
BFLY icon
22
Butterfly Network
BFLY
$2.04B
$57.9M 1.45%
14,335,055
– –
2021 Q1
20 quarters
ESI icon
23
Element Solutions
ESI
$8.69B
$55.6M 1.4%
1,628,683
-1,205,204
-43% -$37.8M
2016 Q3
38 quarters
UAL icon
24
United Airlines
UAL
$31.9B
$45.7M 1.15%
496,860
-14,421
-3% -$1.51M
2025 Q1
4 quarters
EYE icon
25
National Vision
EYE
$1.33B
$40.6M 1.02%
1,565,917
+136,584
+10% +$3.71M
2025 Q2
3 quarters
1
2 3

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Glenview Capital Management held 66 positions worth $3.98B, down 19% from $4.91B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Glenview Capital Management withdrew a net $684M in Q1 2026, closing 22 positions and reducing 15 holdings. Its most notable exit was Expedia Group, an estimated $91.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glenview Capital Management opened a new position in Humana worth $58.1M.

  • Glenview Capital Management's largest Q1 2026 buy was Humana: 334,892 shares worth $58.1M.
  • Glenview Capital Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $71.2M increase.
  • Glenview Capital Management's biggest Q1 2026 reduction was Teva Pharmaceutical Industries Limited, cutting an estimated $324M.
  • Glenview Capital Management fully exited Expedia Group in Q1 2026, selling an estimated $91.1M.
  • Glenview Capital Management's ten largest holdings make up 61% of its $3.98B portfolio in Q1 2026.
  • Glenview Capital Management opened 9 new positions and closed 22 in Q1 2026.
  • Glenview Capital Management's portfolio value fell 19% quarter-over-quarter to $3.98B.

Based on Glenview Capital Management's 13F filing for Q1 2026, filed 15 May 2026.